<DOC>
	<DOCNO>NCT01076348</DOCNO>
	<brief_summary>Safety effectiveness summarize model 4965 lead . This study conduct within Medtronic 's System Longevity Study ( SLS ) .</brief_summary>
	<brief_title>Model 4965 Post-Approval Study</brief_title>
	<detailed_description>As part requirement satisfy PMA Conditions Approval Medtronic Model 4965 CapSure Epi® Steroid-Eluting Unipolar Epicardial Pacing Lead , 50 adult subject ≥19 year old time implant follow one-year post-implant .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Subjects appropriate legal guardian provide write informed consent and/or authorization access use health information , require institution 's IRB/MEC/REB AND one following ( A , B , C ) must also apply : A . Subjects indicate implant within six month postimplant Medtronic marketreleased lead connect marketreleased IPG , ICD , CRT Device . The Medtronic lead must use pacing , sense , defibrillation application . B . Subjects participate qualify study Medtronic cardiac therapy product : product marketreleased complete implant followup data , include productrelated adverse event , available subject appropriate legal guardian authorize release subject study data SLS C. Subjects implant Medtronic CapSure Epi Leads ( model 4965 4968 ) minimum three preselected site retrospectively collect data post approval requirement . Post approval requirement indicate 50 adult subject implant model 4965 100 subject ( pediatric adult ) implant model 4968 . The study plan enroll approximately 100 subject model 4965 lead approximately 200 subject model 4968 lead . Note : Subjects currently active Chronic Lead Study Tachyarrhythmia Chronic Systems Study continue followup phase SLS . Subjects receive implant Medtronic lead nonparticipating center implant data current status confirm within 30 day implant Subjects , inaccessible followup SLS center Subjects implant Medtronic cardiac therapy device whose predetermined enrollment limit specific product exceed Subjects exclusion criterion require local law ( EMEA )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Epicardial</keyword>
	<keyword>Pacing Lead</keyword>
</DOC>